Fingerprint Dive into the research topics of 'An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer
Andrea Necchi, Salvatore Lo Vullo, Luigi Mariani, Daniele Raggi, Patrizia Giannatempo, Giuseppina Calareso, Elena Togliardi, Flavio Crippa, Nicola Di Genova, Federica Perrone, Maurizio Colecchia, Biagio Paolini, Giuseppe Pelosi, Nicola Nicolai, Giuseppe Procopio, Roberto Salvioni, Filippo G. De Braud
Research output: Contribution to journal › Article › peer-review